Controlled Release Drug Delivery Market Report 2024 With Demographic Trends, New Developments, Company Performance and Forecast 2030
The “Global Controlled Release Drug Delivery Market” report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market Global Controlled Release Drug Delivery Market size was valued at USD 44.47 Billion in 2021 and is poised to grow from USD 49.19 Billion in 2022 to USD 110.13 Billion by 2030, at a CAGR of 10.6% during the forecast period (2023-2030).s which include products, applications, and competitor analysis. The report also includes a detailed study of key companies to provide insights into business strategies adopted by various players in order to sustain competition in this highly competitive environment.
- Johnson & Johnson (J&J)
- Pfizer Inc.
- Novartis International AG
- Merck & Co., Inc.
- GlaxoSmithKline plc (GSK)
- AstraZeneca plc
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- Bayer AG
- AbbVie Inc.
- Allergan (acquired by AbbVie)
- Boehringer Ingelheim
- F. Hoffmann-La Roche Ltd (Roche)
- Bristol Myers Squibb (BMS)
- Catalent, Inc.
- Alkermes
- Ipsen
- Gilead Sciences, Inc.
- Biogen Inc.
- Global Controlled Release Drug Delivery Market Size & Forecast by Revenue | 2022−2028
- Global Controlled Release Drug Delivery Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
- Market Segmentation – A detailed analysis by product, by types, end-user, applications, Global Controlled Release Drug Delivery Market size was valued at USD 44.47 Billion in 2021 and is poised to grow from USD 49.19 Billion in 2022 to USD 110.13 Billion by 2030, at a CAGR of 10.6% during the forecast period (2023-2030).s, and geography
- Competitive Landscape – Top key vendors and other prominent vendors
Comments
Post a Comment